See also our related blog for the Pediatric Preclinical Testing Initiative.

Tuesday, December 6, 2011

now in print: EGFR as a Therapeutic Target in Alveolar Rhabdomyosarcoma

[ first posted 2/11/2011 and now updated]

The report of our Pediatric Preclinical Testing Initiative at OHSU on EGFR as a therapeutic target in the childhood muscle cancer rhabdomyosarcoma has been accepted for publication in the journal, Sarcoma.  Co-authors include Keller Lab alumni Sheila Hampton, Courtney Kubicek, Laura Nelon, Aoife Kilcoyne; statistician collaborators Lee Ann Zarzabal and Joel Michalek; experimental therapeutics collaborator Frank Giles; and pathologist collaborator, Brian Rubin.  This work was funded by the Rally Foundation in honor of Matthew Butterfield.  Trainee Jinu Abraham is also a past Scott Carter Foundation fellow.   
[ update 5/11/2011:  the paper can now be viewed online here. ]
[ update 12/06/2011:  the paper is now in print here.  ]